Key Insights

Highlights

Success Rate

100% trial completion (above average)

Published Results

14 trials with published results (38%)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

0.0%

0 terminated out of 37 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

32%

12 trials in Phase 3/4

Results Transparency

45%

14 of 31 completed with results

Key Signals

14 with results100% success

Data Visualizations

Phase Distribution

26Total
Not Applicable (7)
P 1 (1)
P 2 (6)
P 3 (10)
P 4 (2)

Trial Status

Completed31
Unknown3
Enrolling By Invitation1
Withdrawn1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 31 completed trials

Clinical Trials (37)

Showing 20 of 20 trials
NCT06771908Recruiting

THE ROLE OF HEXAMIDINE DIISETHIONATE (ZAMIDINE®) 1MG/ML 0.6ML EYE DROPS IN THE PROPHYLAXIS OF SURGERY OFTALMIC

NCT06469697Not ApplicableCompleted

Zanzibar Arts for Children's Eyesight Pilot Trial

NCT06229379Not ApplicableCompleted

The Effects of a Large Language Model on Clinical Questioning Skills

NCT05430919Phase 2Completed

Efficacy of the Anti-Bet v 1 Monoclonal Antibodies (Given Subcutaneously) to Reduce Allergic Rhinitis and Conjunctivitis Symptoms and Skin Test Reactivity Upon Exposure to Birch Allergen in Adult Participants

NCT06689397Enrolling By InvitationPrimary

Investigating Epstein-Barr Virus Associated Conjunctivitis

NCT06092515Not ApplicableCompleted

Efficacy of Zinc Fortified Fermented Wheat Flour

NCT04374656CompletedPrimary

Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic

NCT04287608CompletedPrimary

Observational Study of Conjunctivitis in the Setting of DUPIXENT® Treatment for Atopic Dermatitis

NCT04709575Phase 3Completed

Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic Rhinitis

NCT03753893Completed

Ocular Manifestations in Rheumatic Diseases

NCT04837534Not ApplicableCompleted

Improving the Follow up Rate for Pediatric Patients

NCT00921895Not ApplicableCompletedPrimary

A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis

NCT04984941Completed

Evaluation of the Role of IgE Responses to Der p 1 and Der p 2 in Chinese House Dust Mite-Allergic Patients

NCT02472223Not ApplicableCompletedPrimary

Reducing Adenoviral Patient Infected Days

NCT04346160Unknown

A Study to Assess the Virus RNA, and miRNA Levels Related to Viral Infection, and Inflammatory Response in Tears of Patients Affected by COVID-19 Disease

NCT03519516Phase 1CompletedPrimary

Safety and Tolerability of the PRO-174 Versus Sophixín Ofteno®, on the Ocular Surface of Healthy Subjects

NCT03631108UnknownPrimary

Feasibility Study and Preliminary Application Study on Iris OCTA

NCT02503956Not ApplicableCompleted

Perforated Punctal Plugs for Treatment of Papillary Conjunctivitis in Otherwise Healthy Patients

NCT00001734CompletedPrimary

Screening for NEI Clinical Studies

NCT00008541Completed

Evaluation and Treatment of Patients With Corneal and External Diseases

Scroll to load more

Research Network

Activity Timeline